Petco CFO Departs, New Directors Appointed

Ticker: WOOF · Form: 8-K · Filed: 2024-04-09T00:00:00.000Z

Sentiment: neutral

Topics: executive-departure, board-changes, management-change

TL;DR

Petco CFO out, interim CFO in, 3 new board members named.

AI Summary

Petco Health & Wellness Company, Inc. announced on April 4, 2024, the departure of Chief Financial Officer, Michael Nuzzo. The company has appointed Brian Laederach as interim CFO. Additionally, the company elected three new directors to its Board: Amy Freeman, Jonathan Kindred, and Christopher Redlich.

Why It Matters

Changes in key executive positions and board composition can signal shifts in company strategy or financial direction, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: medium — Executive departures and board changes can introduce uncertainty regarding leadership stability and strategic direction.

Key Players & Entities

FAQ

Who has been appointed as the interim Chief Financial Officer?

Brian Laederach has been appointed as the interim Chief Financial Officer.

When was the earliest event reported in this filing?

The earliest event reported was on April 4, 2024.

Who is the departing Chief Financial Officer?

Michael Nuzzo is the departing Chief Financial Officer.

How many new directors were elected to the Board?

Three new directors were elected to the Board: Amy Freeman, Jonathan Kindred, and Christopher Redlich.

What is the company's principal executive office address?

The principal executive office address is 10850 Via Frontera, San Diego, California 92127.

From the Filing

0001193125-24-090944.txt : 20240409 0001193125-24-090944.hdr.sgml : 20240409 20240409170107 ACCESSION NUMBER: 0001193125-24-090944 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240404 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240409 DATE AS OF CHANGE: 20240409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Petco Health & Wellness Company, Inc. CENTRAL INDEX KEY: 0001826470 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-RETAIL STORES, NEC [5990] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 811005932 STATE OF INCORPORATION: DE FISCAL YEAR END: 0128 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39878 FILM NUMBER: 24833422 BUSINESS ADDRESS: STREET 1: 10850 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 1-858-453-7845 MAIL ADDRESS: STREET 1: 10850 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 FORMER COMPANY: FORMER CONFORMED NAME: PET Acquisition LLC DATE OF NAME CHANGE: 20200929 FORMER COMPANY: FORMER CONFORMED NAME: Petco Acquisition LLC DATE OF NAME CHANGE: 20200929 8-K 1 d817913d8k.htm 8-K 8-K Petco Health & Wellness Company, Inc. false 0001826470 0001826470 2024-04-04 2024-04-04     UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 4, 2024     Petco Health and Wellness Company, Inc. (Exact name of Registrant as Specified in Its Charter)       Delaware   001-39878   81-1005932 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.) 10850 Via Frontera San Diego , California 92127 (Address of Principal Executive Offices) (858) 453-7845 (Registrant’s Telephone Number, Including Area Code) (Former Name or Former Address, if Changed Since Last Report)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Class A common stock, par value $0.001 per share   WOOF   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On April 4, 2024, the Board of Directors (the “Board”) of Petco Health and Wellness Company, Inc. (the “Company”) approved the termination of employment of Darren MacDonald, the Company’s C

View on Read The Filing